First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

1. Feliu, J.
2. Salud, A.
3. Safont, M.J.
4. García-Girón, C.
5. Aparicio, J.
6. Vera, R.
7. Serra, O.
8. Casado, E.
9. Jorge, M.
10. Escudero, P.
11. Bosch, C.
12. Bohn, U.
13. Pérez-Carrión, R.
14. Carmona, A.
15. Martínez-Marín, V.
16. Maurel, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/BJC.2014.346 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus